摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-甲基-2H-1,4-苯并恶嗪 | 55000-20-9

中文名称
3-甲基-2H-1,4-苯并恶嗪
中文别名
——
英文名称
3-methyl-2H-benzo[1,4]oxazine
英文别名
3-methyl-2H-1,4-benzoxazine;3-methyl-2H-benzo[1,4]oxazine;2-Methyl-3H-1,4-benzoxazin;3-Methyl-2H-1,4-benzoxazin;2H-1,4-Benzoxazine, 3-methyl-
3-甲基-2H-1,4-苯并恶嗪化学式
CAS
55000-20-9
化学式
C9H9NO
mdl
——
分子量
147.177
InChiKey
GMSWGAOENMAHID-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    238.0±33.0 °C(Predicted)
  • 密度:
    1.12±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    21.6
  • 氢给体数:
    0
  • 氢受体数:
    2

SDS

SDS:ebf7f1b2821a5954d7c8c29844096beb
查看

反应信息

  • 作为反应物:
    参考文献:
    名称:
    BARTSCH H.; KROPP W.; PAILER M., MONATSH. CHEM., 1979, 110, NO 2, 257-265
    摘要:
    DOI:
  • 作为产物:
    描述:
    1-(2-硝基苯氧基)乙酮 在 palladium on activated charcoal 氢气三乙胺 作用下, 以 四氢呋喃 为溶剂, 20.0 ℃ 、101.32 kPa 条件下, 反应 7.0h, 以91%的产率得到3-甲基-2H-1,4-苯并恶嗪
    参考文献:
    名称:
    Joung, Meyoung Ju; Ahn, Jin Hee; Kim, Hoe Moon, Journal of Heterocyclic Chemistry, 2002, vol. 39, # 5, p. 1065 - 1069
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • HETEROCYCLIC COMPOUNDS, PROCESS FOR PREPARATION OF THE SAME AND USE THEREOF
    申请人:SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
    公开号:US20170158680A1
    公开(公告)日:2017-06-08
    The present invention provides a heterocyclic compound represented by the formula (I), its stereoisomers, or a pharmaceutically acceptable salt thereof, pharmaceutical compositions thereof, and their use in preparing a medicament for the prevention and/or treatment of central nervous system disease.
    本发明提供了一种由公式(I)表示的杂环化合物,其立体异构体,或其药用可接受的盐,其药物组合物,以及它们用于制备预防或治疗中枢神经系统疾病的药物。
  • METHOD FOR PRODUCING OPTICALLY ACTIVE COMPOUND, AND NOVEL METAL-DIAMINE COMPLEX
    申请人:TAKASAGO INTERNATIONAL CORPORATION
    公开号:US20160347678A1
    公开(公告)日:2016-12-01
    The present invention pertains to a method for producing an optically active compound which includes a step for reducing an imino group of an imine compound or a step for reducing an unsaturated bond of a heterocyclic compound, while in the presence of hydrogen gas as a hydrogen donor and one or more types of complexes selected from a group consisting of a complex represented by general formula (1), a complex represented by general formula (2), a complex represented by general formula (3), and a complex represented by general formula (4) (the general formulas (1)-(4) are as stipulated by claim 1 ).
    本发明涉及一种制备光学活性化合物的方法,其中包括在氢气作为氢供体和从一组中选择的一种或多种类型的配合物的存在下,对亚胺化合物的亚胺基进行还原或对杂环化合物的不饱和键进行还原的步骤,所述配合物的选择自一组由一般式(1)表示的配合物、一般式(2)表示的配合物、一般式(3)表示的配合物和一般式(4)表示的配合物(一般式(1)-(4)如权利要求1所规定)。
  • 2-Cyanobenzolsulfonamide als Pestizide
    申请人:Bayer CropScience AG
    公开号:EP2065370A1
    公开(公告)日:2009-06-03
    Die vorliegende Erfindung beinhaltet 2-Cyanobenzolsulfonamide der Formel (I) in welcher A, R1, R2, R3, R4 und Q und B die in der Beschreibung angegebenen Bedeutungen haben, mehrere Verfahren zu ihrer Herstellung und ihre Verwendung als Wirkstoffe, insbesondere ihre Verwendung als Schädlingsbekämpfungsmittel.
    本发明包括式 (I) 的 2-氰基苯磺酰胺类化合物 其中 A、R1、R2、R3、R4 以及 Q 和 B 的含义如描述中所述,还包括制备它们的多种工艺以及它们作为活性化合物的用途,特别是作为杀虫剂的用途。
  • Probe compound for detecting and isolating enzymes and means and methods using the same
    申请人:Helmholtz-Zentrum für Infektionsforschung GmbH
    公开号:EP2230312A1
    公开(公告)日:2010-09-22
    The present invention relates to a probe compound that can comprise any substrate or metabolite of an enzymatic reaction in addition to an indicator component, such as, for example, a fluorescence dye, or the like. Moreover, the present invention relates to means for detecting enzymes in form of an array, which comprises any number of probe compounds of the invention which each comprise a different metabolite of interconnected metabolites representing the central pathways in all forms of life. Moreover, the present invention relates to a method for detecting enzymes involving the application of cell extracts or the like to the array of the invention which leads to reproducible enzymatic reactions with the substrates. These specific enzymatic reactions trigger the indicator (e.g. a fluorescence signal) and bind the enzymes to the respective cognate substrates. Moreover, the invention relates to means for isolating enzymes in form of nanoparticles coated with the probe compound of the invention. The immobilisation of the cognate substrates or metabolites on the surface of nanoparticles by means of the probe compounds allows capturing and isolating the respective enzyme, e.g. for subsequent sequencing.
    本发明涉及一种探针化合物,它可以包括酶反应的任何底物或代谢物,此外还包括指示成分,例如荧光染料或类似物。此外,本发明还涉及以阵列形式检测酶的方法,该阵列由任意数量的本发明探针化合物组成,每种探针化合物由代表所有生命形式中中心途径的相互关联的代谢物中的不同代谢物组成。此外,本发明还涉及一种检测酶的方法,该方法涉及将细胞提取物或类似物应用于本发明的阵列,从而导致与底物发生可重复的酶反应。这些特定的酶反应会触发指示剂(如荧光信号),并将酶与各自的同源底物结合。此外,本发明还涉及以涂覆有本发明探针化合物的纳米颗粒形式分离酶的方法。通过探针化合物将同源底物或代谢物固定在纳米颗粒表面,可以捕获和分离相应的酶,例如用于后续测序。
  • Heterocyclic compounds, process for preparation of the same and use thereof
    申请人:SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
    公开号:US10174011B2
    公开(公告)日:2019-01-08
    The present invention provides a heterocyclic compound represented by the formula (I), its stereoisomers, or a pharmaceutically acceptable salt thereof, pharmaceutical compositions thereof, and their use in preparing a medicament for the prevention and/or treatment of central nervous system disease.
    本发明提供了一种由式(I)代表的杂环化合物、其立体异构体或其药学上可接受的盐、其药物组合物,以及它们在制备预防和/或治疗中枢神经系统疾病的药物中的用途。
查看更多